{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:04:54Z","timestamp":1789376694310,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1007\/s00403-003-0389-4","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T21:13:12Z","timestamp":1502917992000},"page":"29-32","source":"Crossref","is-referenced-by-count":18,"title":["The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis"],"prefix":"10.1007","volume":"295","author":[{"given":"M.","family":"Kucharekova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hornix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ashikaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"T'kint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. J.","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C. M.","family":"van de Kerkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. G. M.","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,3,4]]},"reference":[{"key":"0389_CR1","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S1367-5931(99)80068-4","volume":"3","author":"Doherty","year":"1999","unstructured":"Doherty AM (1999) Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Curr Opin Chem Biol 3:466\u2013473","journal-title":"Curr Opin Chem Biol"},{"key":"0389_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","volume":"107","author":"Hanifin","year":"1996","unstructured":"Hanifin JM, Chan SC, Cheng JB, et al (1996) Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 107:51\u201356","journal-title":"J Invest Dermatol"},{"key":"0389_CR3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/vr.145.7.191","volume":"145","author":"Ferrer","year":"1999","unstructured":"Ferrer L, Alberola J, Queralt M, et al (1999) Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis. Vet Rec 145:191\u2013194","journal-title":"Vet Rec"},{"key":"0389_CR4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-3565(24)37847-4","volume":"287","author":"Griswold","year":"1998","unstructured":"Griswold DE, Webb EF, Badger AM, et al (1998) SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo. J Pharmacol Exp Ther 287:705\u2013711","journal-title":"J Pharmacol Exp Ther"},{"key":"0389_CR5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0022-3565(25)20790-X","volume":"278","author":"Cohan","year":"1996","unstructured":"Cohan VL, Showell HJ, Fisher DA, et al (1996) In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633. J Pharmacol Exp Ther 278:1356\u20131361","journal-title":"J Pharmacol Exp Ther"},{"key":"0389_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-2999(00)00116-3","volume":"392","author":"Ehinger","year":"2000","unstructured":"Ehinger AM, Gorr G, Hoppmann J, et al (2000) Effects of the phosphodiesterase 4 inhibitor RPR 73401 in a model of immunological inflammation. Eur J Pharmacol 392:93\u201399","journal-title":"Eur J Pharmacol"},{"key":"0389_CR7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0190-9622(94)70059-1","volume":"30","author":"Nickoloff","year":"1994","unstructured":"Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535\u2013546","journal-title":"J Am Acad Dermatol"},{"key":"0389_CR8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI115884","volume":"90","author":"Wood","year":"1992","unstructured":"Wood LC, Jackson SM, Elias PM, et al (1992) Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482\u2013487","journal-title":"J Clin Invest"},{"key":"0389_CR9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0536.1995.tb00478.x","volume":"33","author":"Hoefakker","year":"1995","unstructured":"Hoefakker S, Caubo M, 't Erve EH, et al (1995) In vivo cytokine profiles in allergic and irritant contact dermatitis. Contact Dermatitis 33:258\u2013266","journal-title":"Contact Dermatitis"},{"key":"0389_CR10","unstructured":"Thestrup PK, Halkier SL (1996) Mechanism of irritant contact dermatitis. In: van der Valk PG, Maibach HI (eds) The irritant contact dermatitis syndrome. CRC Press, Boca Raton, pp 305\u2013309"},{"key":"0389_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s002510050032","volume":"51","author":"Allen","year":"2000","unstructured":"Allen MH, Wakelin SH, Holloway D, et al (2000) Association of TNFA gene polymorphism at position \u2212308 with susceptibility to irritant contact dermatitis. Immunogenetics 51:201\u2013205","journal-title":"Immunogenetics"},{"key":"0389_CR12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/intimm\/7.3.343","volume":"7","author":"Lisby","year":"1995","unstructured":"Lisby S, Muller KM, Jongeneel CV, et al (1995) Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms. Int Immunol 7:343\u2013352","journal-title":"Int Immunol"},{"key":"0389_CR13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1600-0625.1997.tb00154.x","volume":"6","author":"Wood","year":"1997","unstructured":"Wood LC, Stalder AK, Liou A, et al (1997) Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol 6:98\u2013104","journal-title":"Exp Dermatol"},{"key":"0389_CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.173.3.673","volume":"173","author":"Piguet","year":"1991","unstructured":"Piguet PF, Grau GE, Hauser C, et al (1991) Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 173:673\u2013679","journal-title":"J Exp Med"},{"key":"0389_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s004030050124","volume":"288","author":"Le","year":"1996","unstructured":"Le M, Schalkwijk J, Siegenthaler G, et al (1996) Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate. Arch Dermatol Res 288:684\u2013690","journal-title":"Arch Dermatol Res"},{"key":"0389_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1034\/j.1600-0536.2002.460603.x","volume":"46","author":"Kucharekova","year":"2002","unstructured":"Kucharekova M, Schalkwijk J, van der Valk PG (2002) Effects of a lipid-rich emollient containing ceramide 3 in an experimentally induced skin barrier dysfunction. Contact Dermatitis 46:331\u2013338","journal-title":"Contact Dermatitis"},{"key":"0389_CR17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0536.1990.tb01553.x","volume":"22","author":"Pinnagoda","year":"1990","unstructured":"Pinnagoda J, Tupker RA, Agner T, et al (1990) Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 22:164\u2013178","journal-title":"Contact Dermatitis"},{"key":"0389_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.1993.tb00222.x","volume":"128","author":"Proksch","year":"1993","unstructured":"Proksch E, Holleran WM, Menon GK, et al (1993) Barrier function regulates epidermal lipid and DNA synthesis. Br J Dermatol 128:473\u2013482","journal-title":"Br J Dermatol"},{"key":"0389_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s004030050384","volume":"291","author":"Castelijns","year":"1999","unstructured":"Castelijns FA, Gerritsen MJ, van Erp PE, et al (1999) Immunohistochemical assessment of keratin 16 on paraffin-embedded sections of normal and hyperproliferative skin: monoclonal antibodies Ks8.12 and LL025 in a comparative study. Arch Dermatol Res 291:59\u201363","journal-title":"Arch Dermatol Res"},{"key":"0389_CR20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/1523-1747.ep13071345","volume":"92","author":"de","year":"1989","unstructured":"de Mare S, van Erp PE, van de Kerkhof PC (1989) Epidermal hyperproliferation assessed by the monoclonal Ks8.12 on frozen sections. J Invest Dermatol 92:130\u2013131","journal-title":"J Invest Dermatol"},{"key":"0389_CR21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00372711","volume":"284","author":"van","year":"1992","unstructured":"van Duijnhoven JL, Schalkwijk J, Kranenborg MH, et al (1992) MON-150, a versatile monoclonal antibody against involucrin: characterization and applications. Arch Dermatol Res 284:167\u2013172","journal-title":"Arch Dermatol Res"},{"key":"0389_CR22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/bj3020363","volume":"302","author":"Siegenthaler","year":"1994","unstructured":"Siegenthaler G, Hotz R, Chatellard-Gruaz D, et al (1994) Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro. Biochem J 302:363\u2013371","journal-title":"Biochem J"},{"key":"0389_CR23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2340\/0001555577014019","volume":"77","author":"Kuijpers","year":"1997","unstructured":"Kuijpers AL, Bergers M, Siegenthaler G, et al (1997) Skin-derived antileukoproteinase (SKALP) and epidermal fatty acid-binding protein (E-FABP): two novel markers of the psoriatic phenotype that respond differentially to topical steroid. Acta Derm Venereol 77:14\u201319","journal-title":"Acta Derm Venereol"},{"key":"0389_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0536.1997.tb00369.x","volume":"37","author":"Le","year":"1997","unstructured":"Le TK, De Mon P, Schalkwijk J, et al (1997) Effect of a topical corticosteroid, a retinoid and a vitamin D3 derivative on sodium dodecyl sulphate induced skin irritation. Contact Dermatitis 37:19\u201326","journal-title":"Contact Dermatitis"},{"key":"0389_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1034\/j.1600-0846.2001.070402.x","volume":"7","author":"Levin","year":"2001","unstructured":"Levin C, Zhai H, Bashir S, et al (2001) Efficacy of corticosteroids in acute experimental irritant contact dermatitis? Skin Res Technol 7:214\u2013218","journal-title":"Skin Res Technol"},{"key":"0389_CR26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0190-9622(89)70219-X","volume":"21","author":"van","year":"1989","unstructured":"van der Valk PG, Maibach HI (1989) Do topical corticosteroids modulate skin irritation in human beings? Assessment by transepidermal water loss and visual scoring. J Am Acad Dermatol 21:519\u2013522","journal-title":"J Am Acad Dermatol"},{"key":"0389_CR27","doi-asserted-by":"crossref","unstructured":"Berardesca E (1995) Acute irritant dermatitis: effect on short-term topical corticoid treatment. In: Surber C, Elsner P, Bircher A (eds) Exogenous dermatology. Karger, Basel, pp 86\u201390","DOI":"10.1159\/000424237"},{"key":"0389_CR28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1600-0536.1995.tb00784.x","volume":"32","author":"Ramsing","year":"1995","unstructured":"Ramsing DW, Agner T (1995) Efficacy of topical corticosteroids on irritant skin reactions. Contact Dermatitis 32:293\u2013297","journal-title":"Contact Dermatitis"},{"key":"0389_CR29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1523-1747.2000.00056.x","volume":"115","author":"Newby","year":"2000","unstructured":"Newby CS, Barr RM, Greaves MW, et al (2000) Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate. J Invest Dermatol 115:292\u2013298","journal-title":"J Invest Dermatol"},{"key":"0389_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0625.1999.tb00380.x","volume":"8","author":"Man","year":"1999","unstructured":"Man MQ, Wood L, Elias PM, et al (1999) Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice. Exp Dermatol 8:261\u2013266","journal-title":"Exp Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-003-0389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-003-0389-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-003-0389-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-003-0389-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:06:31Z","timestamp":1750806391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-003-0389-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["0389"],"URL":"https:\/\/doi.org\/10.1007\/s00403-003-0389-4","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}